GlassScriptPhysician profile
Winfred C Manda
NPI 1659384980
$10,740.93
in general payments reported to CMS, 2019-2025
23 companies · $6,704 in 2025
The $6,704 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $140 · 2021: $105 · 2022: $40.31 · 2023: $140 · 2024: $2,797 · 2025: $6,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,516 · Food and Beverage: $726 · Travel and Lodging: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,516.24 |
| Food and Beverage | $726.27 |
| Travel and Lodging | $398.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,962.18 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $584.69 | 2019-2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $431.75 | 2019-2025 | Trelegy Ellipta, Nucala |
| Verona Pharma, INC. | $190.46 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $83.49 | 2019 | |
| Insmed, INC. | $47.16 | 2025 | Arikayce |
| Portola Pharmaceuticals, LLC | $46.40 | 2019 | |
| Grifols USA, LLC | $45.20 | 2019-2020 | |
| Resmed Corp | $41.96 | 2019-2025 | |
| Mylan Specialty L.P. | $34.64 | 2019 | |
| Philips North America LLC | $33.99 | 2024 | (Ak6) Vest Therapy |
| Viatris Specialty LLC | $32.23 | 2025 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.73 | 2019 | |
| Mallinckrodt Hospital Products INC. | $24.26 | 2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $21.18 | 2023 | Fasenra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.81 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Enterprises LLC | $19.55 | 2019 | |
| Shire North American Group INC | $17.31 | 2019 | |
| Ethicon INC. | $17.21 | 2025 | Monarch Platform |
| Circassia INC. | $17.17 | 2020 | |
| Electromed, INC. | $14.03 | 2023 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $13.45 | 2019 | |
| Gilead Sciences, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winfred Manda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.